AnalyticsIQ, the leading people-based data innovator, and Diaceutics, a leading technology and solutions provider to the pharmaceutical and biotech industry, today announced a strategic partnership to deliver a new generation of high-impact HCP audiences designed to revolutionize how life sciences brands engage and market to providers.

Through this collaboration, the two companies will co-develop over 100 advanced audience segments uniting AnalyticsIQ’s predictive behavioral insights on healthcare providers with Diaceutics’ multimodal clinical data, with lab and genomic insights at its core. Combining these innovative datasets empowers pharma marketers to reach HCPs not just based on what they treat but who they are as individuals. Each audience blends AnalyticsIQ’s Provider-as-a-Person Intelligence which predicts behavioral, attitudinal, and communication preferences with Diaceutics real world laboratory and genomic testing insights to deliver unprecedented visibility into both a provider’s mindset and the patient populations they serve.

These co-developed audiences will initially be available for activation in DeepIntent’s Audience Marketplace and the Doceree Marketplace, with availability across leading healthcare marketing platforms coming soon.

Audience Attributes Include: 

Predictive personal insights from AnalyticsIQ’s Provider-as-a-Person Intelligence including:

• Tech-forward and early-adopter HCPs
• Bilingual (English/Spanish) providers
• Frequent podcast listeners
• HCPs who make business decisions within their organizations

Diaceutics delivers clinically rich patient and HCP insights across a range of therapeutic areas including:

• Chronic diseases guided by lab-based diagnostics such as diabetes, hypercholesterolemia, and rheumatoid arthritis
• Patients with precision medicine targeted therapies in breast, lung, and prostate cancers
• Biomarker-specific segments, including HER2+, EGFR+, PDL1+, and more

The result is a suite of 100+ curated HCP audiences that offer a dual lens into a provider's clinical focus and the HCP as a consumer including personal engagement style enabling more personalized, data-driven strategies that resonate.

“With Provider-as-a-Person Intelligence, our mission has always been to help marketers understand healthcare providers beyond their credentials,” said Christine Lee, Head of Health Strategy at AnalyticsIQ. “By combining our people-based insights with Diaceutics’ world-class clinical data, we’re enabling pharma brands to finally personalize engagement at both the clinical and human level—unlocking smarter strategies and better outcomes.”

With 70% of clinical decisions based on diagnostic test results according to the CDC, this new level of audience intelligence enables pharma marketers to engage clinically relevant HCPs on the right channels with messaging that resonates, ultimately driving the adoption of the right therapies to improve patient outcomes

“This partnership is a natural extension of our commitment to improving patient outcomes through precision medicine,” said Scott Phillips, VP of Real World Data at Diaceutics. By linking our real-world diagnostic and treatment insights with AnalyticIQ’s behavioral intelligence, we’re enabling life science teams to identify and activate the right providers with messaging that truly resonates, ensuring those providers are empowered to make the right decisions for their patients from the start.”

With this launch, AnalyticsIQ and Diaceutics set a new standard for HCP audience intelligence by uniting two powerful data dimensions that have never before been available in a single solution. This innovative approach positions pharma and life sciences marketers at the forefront of precision engagement, equipping them to lead the way in connecting with providers in more meaningful, impactful ways.